Haemophilus influenzae type b. Conjugate vaccines for use in infants and children.
Haemophilus influenzae type b (Hib) is a bacterial pathogen that causes serious, sometimes fatal, infections primarily in young children, especially in the second 6 months of life. Immunisation of children against Hib is now an important issue and four conjugate Hib vaccines have become available. The various vaccines, and their characteristics are documented in this paper.
Hanna
J N
JN
Centre for Disease Control, Tropical Public Health Unit, Cairns, Queensland.
Steven
I D
ID
Plant
A J
AJ
D000367:Age Factors; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D002675:Child, Preschool; D004334:Drug Administration Schedule; D006192:Haemophilus Infections / Q000382:microbiology / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid; D016896:Treatment Outcome; D014614:Vaccines, Synthetic
D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C055753:Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011135:Polysaccharides, Bacterial; D013745:Tetanus Toxoid; D014614:Vaccines, Synthetic; C061963:HibTITER protein, Haemophilus influenzae